Filter Articles
Statement from Professor Lunn in Reference to Newest Research on COVID-19, GBS, and Vaccines
In reaction to recent research published in Brain (click here to read more), Professor Lunn…
New Study Reveals No Association Between COVID-19 and Guillain-Barré Syndrome
The GBS|CIDP Foundation is committed to sharing the most accurate information from the world’s leading…
Covid19, Ask the Expert
Virtual Ask the Experts Series April 22, 2020 - Dr. Ken Gorson Part of our virtual…
The COVID-19 Rare Disease Critical Needs Non-Medical Assistance Fund from The National Organization of Rare Disorders
The National Organization of Rare Disorders (NORD) launched a COVID-19 Critical Relief Program to provide…
Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19
Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19
What is Convalescent Plasma?
By Dr. David Saperstein Antibodies (also known as immunoglobulins) play an important role in health…
Resource from PPTA Regarding COVID-19
The Plasma Protein Therapeutics Association (PPTA) has provided a statement specific to plasma protein therapies…
A statement from the GBS|CIDP Foundation regarding the COVID-19
The coronavirus COVID-19 situation is evolving rapidly. In the interest of concerns and questions that…